Form 4: Thermo Fisher Director Acquires Phantom Stock Units

Thermo Fisher Scientific Inc. director Dion J. Weisler acquired phantom stock units under the company's Deferred Compensation Plan for Directors.

Summary

• Dion J. Weisler, a Director at Thermo Fisher Scientific Inc., acquired 73.1 phantom stock units on June 27, 2026.
• These units were credited under the company's Deferred Compensation Plan for Directors.
• Each unit is convertible into one share of Common Stock.
• The acquisition price per unit was $513.03, based on the closing stock price as of the quarter end.
• Following this transaction, Weisler beneficially owns 2,790.99 units directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation event for a director rather than a significant strategic or financial development.

Positives

• Director participation in equity-based compensation plans, aligning personal interests with shareholder value.
• The acquisition reflects continued commitment from a key board member.
• The phantom stock units are valued at a price reflecting the current market performance of Thermo Fisher Scientific's common stock.

Negatives

• The filing details an acquisition of phantom stock units, not a purchase of common stock with personal funds, which may be perceived differently by some investors.
• The value of these units is tied to future stock performance, introducing market risk for the director.

Risks

• The value of the phantom stock units is subject to market fluctuations of Thermo Fisher Scientific's common stock.
• Distribution of shares is contingent upon cessation of director service or a change of control, introducing timing uncertainty.

Future Outlook

The phantom stock units are distributable as stock upon cessation of director service or a change of control, indicating potential future share issuance tied to these events.

Management Comments

• "Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end."
• "The shares are distributable as stock upon cessation of director service (for any reason) or a change of control."

Industry Context

StockSavvy.ai notes that the use of phantom stock units under a deferred compensation plan is a common practice among large-cap companies in the life sciences and healthcare technology sectors, including Thermo Fisher Scientific, to attract and retain experienced directors by aligning their compensation with long-term shareholder interests.

Related Party Transactions

• The acquisition of phantom stock units by Director Dion J. Weisler under the Issuer's Deferred Compensation Plan for Directors is a related party transaction.

Stakeholder Impact

• Shareholders: The transaction reinforces director alignment with shareholder interests through equity-based compensation, but the value is subject to market performance.
• Employees: This filing does not directly impact employees but reflects the company's compensation practices for its board.
• Management: The transaction is part of the established compensation structure for directors.

Next Steps

• Distribution of common stock upon cessation of director service or a change of control.

Key Dates

Keywords

Thermo Fisher Scientific, TMO, Form 4, Insider Trading, Director Compensation, Phantom Stock Units, Deferred Compensation Plan, Beneficial Ownership, Equity Compensation